FDA Inspection 1044840 — Voyant
The FDA completed an inspection of Voyant on Mar 7, 2018 in Danville, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2018
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Danville, IL (United States)